Clinical Trial Update: A Study to Investigate the Safety of GSK4024484 in Healthy Adult Participants [Phase 1]

View source ↗

Summary

A Phase 1 study to assess the safety of GSK4024484 in healthy adults is actively recruiting, sponsored by GlaxoSmithKline, for Plasmodium falciparum malaria.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plasmodium Falciparum Malaria

Drugs mentioned

• GSK4024484

Snippet

Sponsor: GlaxoSmithKline | Conditions: Malaria, Falciparum | Phase 1 | Status: RECRUITING